IMMUNIC IMUX 深 沪
已收盘 09-20 16:00:00 美东时间
1.83
-0.120
-6.15%
华盛通- 最 高2.08
- 今 开1.98
- 成交量 92.93万股
- 最 低 1.8299
- 昨 收 1.95
- 总市值 1.65亿
- 52周最高 2.11
- 市盈率 静 --
- 换手率 1.03%
- 52周最低 0.9451
- 委 比 95.34%
- 总股本 8992.90万
- 历史最高 28.99
- 量 比 0.83
- 振 幅 12.83%
- 历史最低 0.9451
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-16 21:27
Leerink Partners Likes “Risk/Reward” of Immunic’s CALLIPER Readout
Leerink Partners analyst Faisal Khurshid said that he likes the “risk/reward” p...
09-16 16:55
Immunic CEO Says “Right Time” to Buy the Stock Now – Part 2
In our previous article on Immunic ($IMUX), we highlighted some of the importan...
09-02 17:28
Immunic Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-27 18:10
快讯 | Immunic公司：b. Riley给予买入评级；目标价为$6
Immunic Inc : B. Riley Initiates Coverage With Buy Rating; Target Price $6
08-27 11:22
快讯 | Immunic，Inc. 将公布截至2024年6月30日的第二季度财务业绩并提供公司更新
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 3...
08-01 18:30
快讯 | 药品公司Immunic, Inc.任命经验丰富的药品执行官Simona Skerjanec加强其董事会。
Immunic, Inc. Strengthens Its Board of Directors With the Appointment of Experi...
07-24 18:30
Immunic Stock (NASDAQ:IMUX): Exploring the Promising Phase 2 CALLIPER Trial
Immunic, Inc. ($IMUX) is a clinical-stage biotechnology company, headquartered ...
07-22 17:27
Piper Sandler Reiterates Overweight on Immunic, Maintains $28 Price Target
Piper Sandler analyst Yasmeen Rahimi reiterates Immunic (NASDAQ:IMUX) with a Overweight and maintains $28 price target.
07-16 23:44
Immunic appoints Jason Tardio as COO and President
Immunic (NASDAQ:IMUX) said it has appointed Jason Tardio to the newly created role of COO and President, effective July 12, 2024. Tardio most recently served as COO of Ovid Therapeutics since June 202...
07-09 18:45
